Competitive Dynamics and Technological Progress in the US Mycoplasma Testing Market
The US mycoplasma testing market is on the cusp of significant advancements, with numerous trends set to influence its trajectory. Projections indicate that the market is poised to achieve a size of USD 1,529.59 million by 2035, growing at a compound annual growth rate (CAGR) of 11.45%. This growth is largely attributed to rising demand for quality assurance in biopharmaceutical production and...
0 Commentarii 0 Distribuiri 33 Views 0 previzualizare